Belararox Statistics

Total Valuation

Belararox has a market cap or net worth of AUD 19.44 million. The enterprise value is 8.99 million.

Market Cap	19.44M
Enterprise Value	8.99M

Important Dates

The next estimated earnings date is Wednesday, June 11, 2025.

Earnings Date	Jun 11, 2025
Ex-Dividend Date	n/a

Share Statistics

Belararox has 143.96 million shares outstanding. The number of shares has increased by 133.17% in one year.

Current Share Class	n/a
Shares Outstanding	143.96M
Shares Change (YoY)	+133.17%
Shares Change (QoQ)	+5.74%
Owned by Insiders (%)	13.25%
Owned by Institutions (%)	7.05%
Float	82.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1,651.25
PB Ratio	0.72
P/TBV Ratio	0.72
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.26
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.28

Financial Position

The company has a current ratio of 5.48

Current Ratio	5.48
Quick Ratio	5.22
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-13.45

Financial Efficiency

Return on equity (ROE) is -21.08% and return on invested capital (ROIC) is -12.49%.

Return on Equity (ROE)	-21.08%
Return on Assets (ROA)	-10.15%
Return on Invested Capital (ROIC)	-12.49%
Return on Capital Employed (ROCE)	-12.71%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -38.64% in the last 52 weeks. The beta is -1.13, so Belararox's price volatility has been lower than the market average.

Beta (5Y)	-1.13
52-Week Price Change	-38.64%
50-Day Moving Average	0.15
200-Day Moving Average	0.21
Relative Strength Index (RSI)	44.05
Average Volume (20 Days)	1,049,375

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Belararox had revenue of AUD 11,770 and -3.98 million in losses. Loss per share was -0.03.

Revenue	11,770
Gross Profit	11,770
Operating Income	-3.78M
Pretax Income	-3.98M
Net Income	-3.98M
EBITDA	-3.77M
EBIT	-3.78M
Loss Per Share	-0.03

Full Income Statement

Balance Sheet

The company has 10.45 million in cash and n/a in debt, giving a net cash position of 10.45 million or 0.07 per share.

Cash & Cash Equivalents	10.45M
Total Debt	n/a
Net Cash	10.45M
Net Cash Per Share	0.07
Equity (Book Value)	26.84M
Book Value Per Share	0.19
Working Capital	9.11M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.35 million and capital expenditures -4.66 million, giving a free cash flow of -7.01 million.

Operating Cash Flow	-2.35M
Capital Expenditures	-4.66M
Free Cash Flow	-7.01M
FCF Per Share	-0.05

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-32,083.65%
Pretax Margin	-33,833.98%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Belararox does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-133.17%
Shareholder Yield	-133.17%
Earnings Yield	-20.49%
FCF Yield	-36.07%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Belararox has an Altman Z-Score of 2.22. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.22
Piotroski F-Score	n/a